Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong
· Delayed Price · Currency is HKD 12.20
+0.18 (1.50%)
Apr 24, 2025, 4:08 PM HKT
Medlive Technology Revenue
In the year 2024, Medlive Technology had annual revenue of 558.46M CNY with 35.55% growth. Medlive Technology had revenue of 315.01M in the half year ending December 31, 2024, with 72.99% growth.
Revenue
558.46M CNY
Revenue Growth
+35.55%
P/S Ratio
15.04
Revenue / Employee
747.60K CNY
Employees
747
Market Cap
8.94B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| CSPC Pharmaceutical Group | 30.87B |